Soy Protein Toxicity Data Needed To Support Health Claim - Researchers
This article was originally published in The Tan Sheet
Executive Summary
FDA's proposed health claim for soy protein and prevention of coronary heart disease is premature without human safety data on the ingredient, researchers from the HHS National Center for Toxicological Research assert in Feb. 18 comments to the agency.
You may also be interested in...
Soy Protein Safety Concerns Lack Human Adverse Effect Data - FDA
Challenges to the safety of soy protein-containing foods failed to provide documented evidence of adverse effects in humans or any information "about actual levels of potentially harmful components or about threshold levels for adverse effects in humans," FDA says in its approved soy protein health claim.
Soy Protein Safety Concerns Lack Human Adverse Effect Data - FDA
Challenges to the safety of soy protein-containing foods failed to provide documented evidence of adverse effects in humans or any information "about actual levels of potentially harmful components or about threshold levels for adverse effects in humans," FDA says in its approved soy protein health claim.
Soy Protein Safety Concerns Lack Human Adverse Effect Data - FDA
Challenges to the safety of soy protein-containing foods failed to provide documented evidence of adverse effects in humans or any information "about actual levels of potentially harmful components or about threshold levels for adverse effects in humans," FDA says in its approved soy protein health claim.